Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.

Idowu BD, Thomas G, Frow R, Diss TC, Flanagan AM.

Br J Oral Maxillofac Surg. 2008 Apr;46(3):229-230. doi: 10.1016/j.bjoms.2007.04.014. Epub 2007 Jun 4.

PMID:
17544554
2.

Epidermal growth factor receptor expression and activation in neuroendocrine tumours.

Shah T, Hochhauser D, Frow R, Quaglia A, Dhillon AP, Caplin ME.

J Neuroendocrinol. 2006 May;18(5):355-60.

PMID:
16629834
3.

Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala.

McLean SR, Gana-Weisz M, Hartzoulakis B, Frow R, Whelan J, Selwood D, Boshoff C.

Mol Cancer Ther. 2005 Dec;4(12):2008-15.

4.

A molecular map of mesenchymal tumors.

Henderson SR, Guiliano D, Presneau N, McLean S, Frow R, Vujovic S, Anderson J, Sebire N, Whelan J, Athanasou N, Flanagan AM, Boshoff C.

Genome Biol. 2005;6(9):R76. Epub 2005 Aug 26.

5.

Three retained upper right deciduous teeth at 42 years of age. A case report.

Frow RF.

Dent Delin. 1968 Winter;19(4):7-8 passim. No abstract available.

PMID:
5250640

Supplemental Content

Support Center